Date Filer Title Filing Type Shares Traded Price Total Held
Apr 01, 2021
Chief Operating Officer
Chief Operating Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
Apr 01, 2021
Chief Financial Officer
Chief Financial Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
May 12, 2021
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 290,000 -- 295,191
May 12, 2021
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 290,000 -- 585,191
Feb 18, 2020
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 290,000 -- 290,000
Feb 15, 2023
Director, President and CEO
Director, President and CEO Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 841,615
Sep 01, 2020
Chief Medical Officer
Chief Medical Officer Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 300,000
Sep 01, 2020
Chief Medical Officer
Chief Medical Officer Form 4/A Grant, award or other acquisition pursuant to Rule 16b-3(d) 300,000 -- 300,000
Dec 30, 2021
Chief Informatics Officer
Chief Informatics Officer Form 5 Bona fide gift 318,899 -- 5,006,479
Aug 23, 2018
Ten Percent Owner
Ten Percent Owner Form 4 Conversion of derivative security 337,694 $4.59 929,878

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.